To investigate the regulatory mechanisms underlying METTL3 upregulation in pancreatic cancer, we isolated METTL3-associated protein complexes from pancreatic cancer cells by co-IP assay. The gene discussed is METTL3; the disease is familial pancreatic carcinoma.